Volume 18, Number 2—February 2012
Research
Effect of Surveillance Method on Reported Characteristics of Lyme Disease, Connecticut, 1996–2007
Starr-Hope Ertel
, Randall S. Nelson, and Matthew L. Cartter
, Randall S. Nelson, and Matthew L. CartterTable 3
Clinical manifestations of Lyme disease, by surveillance method, Connecticut, 1996–2007*
| Clinical manifestations | No. (%) cases |
||||
|---|---|---|---|---|---|
| PS, n = 12,185 | AS, n = 8,666 | ELS, n = 1,949 | MLS, n = 10,657 | Total, n = 33,457 | |
| Erythema migrans only | 9,489 (77.9) | 6,324 (73.0) | 1,032 (53.0) | 5,305 (49.8) | 22,150 (66.2) |
| Late manifestations only | 2,059 (16.9) | 1,725 (19.9) | 763 (39.1) | 4,678 (43.9) | 9,225 (27.6) |
| Both | 637 (5.2) | 617 (7.1) | 154 (7.9) | 674 (6.3) | 2,082 (6.2) |
*PS, passive surveillance; AS, active surveillance; ELS, enhanced laboratory surveillance; MLS, mandatory laboratory surveillance.
